Jump to top navigation [1]
Jump to side navigation [2]
Jump to main content [3]

A

AADA
Abbreviated Antibiotic Drug Application
ABPI
Association of British Pharmaceutical Industries
ACE
Adverse Clinical Event
ACRA
Associate Commissioner for Regulatory Affairs
ACRPI
Association for Clinical Research in the pharmaceutical Industry (UK)
ACT
Applied Clinical Trials
ADE
Adverse Drug Event, Adverse Drug Effect
ADR
Adverse Drug Reaction
AERS
Adverse Event Reporting System
AHA
Area Health Authority
AICRC
Association of Independent Clinical Research Contractors (UK)
ANDA
Abbreviated New Drug Application
API
Active Pharmaceutical Ingredients
AQL
Acceptable Quality Level
ARENA
Applied Research Ethics National Association
ASMF
Active Substance Master Files
ASR
Annual Safety Report
ASPR
Anonymised Single Patient Report
ATSDR
Agency for Toxic Substance & Disease Registry
ADME
Absorption, Distribution, Metabolism and Excretion

B

BAPP
British Association of Pharmaceutical Physicians
BARQA
British Association of Research Quality Assurance
BCE
Beneficial Clinical Event
BGMA
The British Generic Manufacturer's Association
BMA
British Medical Association
BIO
Biotechnology Industry Association
BP
British Pharmacopoeia
BROMI
Better Regulations of Medicines Initiative

C

CAs
Competent Authorities (EU)
CD
Controlled Drug
CEP
Certificate of European Pharmacopeia (certificate of suitability)
CAPRA
Canadian Association of Pharmaceutical Regulatory Affairs
CBER
Centre for Biologics Evaluation and Research
CCDS
Company Core Data Sheet
CCSI
Company Core Safety Information
CDC
Centres for Disease Control and Prevention
CDER
Centre for Drug Evaluation and Research
CDRH
Centre for Devices and Radiological Health
CFSAN
Centre for Food Safety and Applied Nutrition
CIB
Clinical Investigators Bureau
CIOMS
Council for International Organisations of Medical Sciences (WHO)
CHMP
Committee for Medicinal Products for Human Use
CMC
Chemistry and Manufacturing Controls
CMS
Concerned Member State
CPMP
Committee for Proprietary Medicinal Products (EMA)
CSD
Committee on Safety of Medicines (UK)
CRA
Clinical Research Associate
CRC
Clinical Research Coordinator
CRO
Clinical Research Organisation
CSA
Clinical Study Agreement
CSM
Committee on Safety of Medicines (UK)
CSR
Clinical Study Report
CTA
Clinical Trail Application
CTD
Common Technical Document
CTD
Clinical Trail Directive
CTC
Clinical Trial Certificate
CTX
Clinical Trial Exemption
CP
Centralised Procedure
CPP
Certificate of Pharmaceutical Product
CRO
Contract Research Organisation
CTA
Clinical Trial Application
CTC
Clinical Trial Certificate
CUVP
The Committee for Veterinary Medicinal Products (EMA)

D

DB
Double Blind
DB
Device Bulletin
DCF
Data Clarification Request Form
DCP
Decentralised Procedure
DHCP
Dear Healthcare Professional Communication
DCSI
Development Core Safety Information
DSUR
Development Safety Update Report
DDPS
Detailed Description of Pharmacovigilance System
DESI
Drug Efficacy Study Implementation
DHR
Device History Record
DIA
Drug Information Association
DMC
Data Monitoring Committee
DMF
Drug Master File
DMR
Drug Master Record
DMRC
Defective Medicines Report Centre
DRF
Drug Range Finding (Study)
DSMB
Data and Safety Monitoring Board

E

EAB
Ethical Advisory Board
EC
European Commission
EC
European Community
eCTD
Electronic Common Technical Document
EEA
European Economic Area
EDQM
European Directive for the Quality of Medicines and Healthcare
EFPIA
European Federation of Pharmaceutical Industry Associations
EFTA
European Free Trade Association
EMA
European Medicines Agency
EOP1
End of Phase1
EOP2
End of Phase2
EPRG
European Pharmacovigilance Research Group
EPAR
European Public Assessment Report
EP
European Pharmacopeia
ESRA
European Society of Regulatory Affairs
EUCOMED
European Confederation of Medical Devices Association
EQA
European Quality Award
EU
European Union
EUDRA
European Union Drug Regulatory Authorities

F

FDA
Food and Drug Administration
FOI
Freedom of Information
FOIA
Freedom of Information Act

G

GCP
Good Clinical Practice
GDP
Good Distribution Practise
GHTF
Global Harmonisation Task Force
GGP
Good Guidance Practice
GLP
Good Laboratory Practice
GMDN
Global Medical Device Nomenclature
GMO
Genetically Modified Organisms
GMP
Good Manufacturing Practise
GPvP
Good Pharmacovigilance Practise

H

HIMA
Health Industry Manufacturers Association
HCP
Health Care Professional

I

IB
Investigational Brochure
IBD
International Birth Date
ICDRA
International Conference of Drug Regulatory Authorities
ICH
International Conference on Harmonisation
ICSR
Individual Case Safety Report
IDE
Investigational Device Exemption
IDR
Idiosyncratic Drug Reaction
IDBM
Independent Data Monitoring Board
IEC
Independent Ethics Committee
ILAR
Institute for Laboratory Animal Research
IMB
Irish Medicines Board
IMP
Investigational Medicinal Products
IMPD
Investigational Medicinal Product Dossier
IMS
Information Management Strategy
IND
Investigational New Drug (application)
INDC
Investigational New Drug Committee
INN
International Approved Names for Pharmacopoeial Substances
IPRO
Independent Pharmaceutical Research Organisation
IRD
International Registration Document
IRB
Institutional Review Board
ISE
Integrated Summary of Efficacy
ISO
International Standards Organization
ITT
Intent to Treat
IVD
In Vitro Device, In Vitro diagnosis

L

LOA
Letter of Agreement
LOQ
Limit of Quantification
LOD
Limit of Detection

M

MA
Marketing Authorisation
MAA
Marketing Authorisation Application
MAD
Multiple Ascending Dose
MAH
Marketing Authorisation Holder (EC)
MCA
Medicines Control Agency (UK)
MDA
Medical Device Agency (UK)
MDA
Medical Device Alert
MDD
Medical Device Directive
MDI
Metered Dose Inhaler
MDLO
Medical Device Liaison Officer
MEdDRA
Medical Dictionary for Drug Regulatory Affairs
ML
Manufacturers Licence
MDMA
Medical Device Manufacturers Association
MDR
Medical Device Reporting
MDR
Medical Device Regulation
MDV
Medical Device Vigilance
MDD
Medical Device Directives (EU)
MLD
Minimum Lethal Dose
MPA
Multiple Project Assurance
MRA
Multiple Recognition Agreements
MRD
Multiple Rising Dose
MRP
Mutual Recognition Procedure
MTD
Maximum Tolerated Dose
MHRA
Medicines and Healthcare Products Regulatory Agency

N

NADA
New Animal Drug Application
NAS
New Active Substance
NBs
Notified Bodies (EU)
NCBI
National Centre for Biotechnology Information
NCCLS
National Committee of Clinical laboratory Standards
NCE
New Chemical Entity
NCI
National Cancer Institute
NCPIE
National Council on Patient Information and Education
NCTR
National Council for Toxicological Research
NDA
New Drug Application
NDBA
National Drugs Advisory Board (Ireland)
NDAC
Non-prescription Drugs Advisory Committee
NIAID
National Institute of Allergies and Infectious Diseases (NIH)
NIBSC
National Institute for Biological Standards and Control
NIH
National Institutes of Health
NINDS
National Institutes of Neurological Disorders and Stroke (NIH)
NME
New Molecular Entity
NMI
Non Medicinal Ingredients
NPA
The National Pharmaceutical Association (UK)
NRC
Nuclear Regulatory Commission
NSAID
Nonsteroidal Anti-inflammatory Drug
NTA
Notice to Applicants

O

ODD
Orphan Drug Designation
OTC
Over the Counter (drugs)

P

PAGB
Proprietary Association of Great Britain
PD
Pharmacodynamics
PAPs
Product Analysis Prints
PASS
Post Authorisation Safety Study
PCT
Primary Care Trust
PDA
Parenteral Drug Association
PDP
Product Development Protocols (for Medical Devices)
PER
Pharmaceutical Evalution Reports (EMA)
PI
Package Inserts
PIL
Patient Information Leaflet
PIP
Paediatric Investigation Plan
PL
Product Licence
PK
Pharmacokinetics
POM
Prescription Only Medicine
PMA
Pre-Market Approval (Application) (for Medical Devices)
PMS
Post Marketing Surveillance
PRRs
Proportioned Reporting Ratios
PSI
Pharmaceutical Society of Ireland
PSNI
Pharmaceutical Society of Northern Ireland
PSUR
Periodic Safety Update Report (EMA)
PUMA
Paediatric Use Marketing Authorisation
PV
Pharmacovigilance

Q

QA
Quality Assurance
QC
Quality Control
QOS
Quality Overall Summary
QRD
Quality Review of Documents
QP
Qualified Person
QPPV
Qualified Person for Pharmacovigilance
QM
Quality Management

R

RAMA
Remote Access for Marketing Authorisations
R&D
Research and Development
rINN
recommended International Non-proprietary Name
RMP
Risk Management Plan
RAPS
Regulatory Affairs Professional Society (USA)
RPSGB
Royal Pharmaceutical Society of Great Britain
RMS
Reference Member State
RSI
Reference Safety Information
RP
Responsible Person

S

SAD
Single Ascending Dose
SAE
Serious Adverse Event
SAL
Sterility Assurance Level
SAMM
Safety Assessment of Marketed Medicines
SBA
Summary Basis of Approval
SCT
Society for Clinical Trials
SME
Significant Medical Event
SME
Subject Matter Expert
SMF
Site Master File
SMQ
Standardised MedDRA Query
SMT
Safety Management Team
SOCRA
Society of Clinical Research Associates
SOC
System Organ Class
SOP
Standard Operating Procedure
SPC
Summary of Product Characteristics
SmPC
Summary of Product Characteristics
SQA
Society of Quality Assurance
SRD
Single Rising Dose
SUD
Sudden Unexpected Death
SUSAR
Suspected, Unexpected, Serious adverse reaction

T

TK
Toxicokinetics
TOPRA
The Association for Regulatory Affairs Professionals

U

USAN
United States Adopted Names
USP
United States Pharmacopeia
USPI
United States Product Information
UKPAR
United Kingdom Public Assessment Report

V

VAERS
Vaccine Adverse Event Reporting System
VAMF
Vaccine Antigen Master File

W

WHO
World Health Organisation
WI
Working Instruction
WP
Working Practise
Vicki Kent - Office Manager

Vicki Kent
Office Manager


Registered in the UK, Company No.4291049 - VAT No.776 5540 93
Sitemap | Privacy Policy | Accessibility